Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Transcept Pharmaceuticals has reported net loss of $2.25m for the second quarter ended 30 June 2011, compared to $2.06m for the same period in 2010.
Subscribe to our email newsletter
The company’s loss from operations for the second quarter of 2011 was $2.22m, compared to $2.05m for the same period in 2010.
For the six months ended 30 June 2011, the company reported a net loss of $4.19m, compared to $3.9m for the same period in 2010.
Transcept’s loss from operations was $4.13m for the six months of 2011, compared to $3.89m for the same period in 2010.